Evaluation of (188)Re- IBA as a novel radiopharmaceutical for bone marrow ablation. Ranjbar H, Bagheri R, Miremad SM. Appl Radiat Isot 2024;208:111300.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ranjbar H, Bagheri R, Miremad SM. Evaluation of (188)Re- IBA as a novel radiopharmaceutical for bone marrow ablation. Appl Radiat Isot 2024;208:111300.
PMID: 38531242